LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2009

Aug 14, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC./DE (LXRX)
CIK: 0001062822
Period of Report: 2009-08-12

Reporting Person: Tessmer James F (VP, Finance & Acctg)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-08-12	Common Stock	F	3187	$1.30	Disposed	22613.00	Direct

Footnotes

F1: Withholding of a portion of vested shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.